TABLE 1.
Purpose | Primer(s) (5′–3′)a |
|
---|---|---|
Forward | Reverse | |
PB2 amplification | CCAGCAAAAGCAGGTCAAATATATTCA | TTAGTAGAAACAAGGTCGTTTTTAAAT (DK/08), TTAGTAGAAACAAGGTCGTTTTTAAAC (CK/09) |
PB1 amplification | CCAGCAAAAGCAGGCAAACCATTTGAATG | TTAGTAGAAACAAGGCATTTTTTCACG |
PA amplification | CCAGCAAAAGCAGGTACTGATCCAAA | TTAGTAGAAACAAGGTACTTTTTTGGA |
HA amplification | CCAGCAAAAGCAGGGGTTCACTCTGTC (DK/08), CCAGCAAAAGCAGGGGTCCAATCTGTC (CK/09) | TTAGTAGAAACAAGGGTGTTTTTAACTAC |
NP amplification | CCAGCAAAAGCAGGGTAGATAATCAC | TTAGTAGAAACAAGGGTATTTTTCT |
NA amplification | CCAGCAAAAGCAGGAGTTCA | TTAGTAGAAACAAGGAGT |
M amplification | CCAGCAAAAGCAGGTAGATGT | TTAGTAGAAACAAGGTAGTTT |
NS amplification | CCAGCAAAAGCAGGGTGACAAAAACAT | TTAGTAGAAACAAGGGTGTTTTTTA |
CK/09 PB1D619N mutation | GAAATGGGAATTGATGGATGAAAACTACCAGGGCAG | CTGCCCTGGTAGTTTTCATCCATCAATTCCCATTTC |
CK/09 PB1G622D mutation | GGATGAAGACTACCAGGACAGACTGTGCAATCCTC | GAGGATTGCACAGTCTGTCCTGGTAGTCTTCATCC |
CK/09 PB1R635K mutation | CTGAATCCATTCGTCAGCCATAAGGAAATTGAATCTGTC | GACAGATTCAATTTCCTTATGGCTGACGAATGGATTCAG |
CK/09 PB1D619N/G622D mutation | GGATGAAAACTACCAGGACAGACTGTGCAATCCTC | GAGGATTGCACAGTCTGTCCTGGTAGTTTTCATCC |
The nucleotides that have been changed are underlined and in boldface type.